Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on August 29, 2024. The transaction involved the disposal of 162 shares of Moderna's common stock at a price of $78.026 per share. Following the sale, Klinger holds a total of 17,447 Moderna shares directly. The sale, which is part of an open market or private sale transaction, resulted in a total market value of $12,640.21. This transaction follows a previous acquisition of 329 shares through the exercise or conversion of derivative security on August 28, 2024.

Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on August 29, 2024. The transaction involved the disposal of 162 shares of Moderna's common stock at a price of $78.026 per share. Following the sale, Klinger holds a total of 17,447 Moderna shares directly. The sale, which is part of an open market or private sale transaction, resulted in a total market value of $12,640.21. This transaction follows a previous acquisition of 329 shares through the exercise or conversion of derivative security on August 28, 2024.